InspireMD (NSPR) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

InspireMD Revenue Highlights


Latest Revenue (Y)

$8.98M

Latest Revenue (Q)

$3.40M

Main Segment (Y)

CGuard EPS

Main Geography (Y)

Other Countries

InspireMD Revenue by Period


InspireMD Revenue by Year

DateRevenueChange
2025-12-31$8.98M28.11%
2024-12-31$7.01M12.96%
2023-12-31$6.21M20.00%
2022-12-31$5.17M15.04%
2021-12-31$4.50M80.89%
2020-12-31$2.48M-33.22%
2019-12-31$3.72M3.33%
2018-12-31$3.60M30.42%
2017-12-31$2.76M45.78%
2016-12-31$1.89M-18.01%
2015-12-31$2.31M-18.03%
2014-12-31$2.82M-42.17%
2013-06-30$4.87M-8.90%
2012-06-30$5.35M-10.91%
2011-12-31$6.00M100.00%
2010-06-30--100.00%
2009-06-30$3.41M-

InspireMD generated $8.98M in revenue during NA 2025, up 28.11% compared to the previous quarter, and up 361.33% compared to the same period a year ago.

InspireMD Revenue by Quarter

DateRevenueChange
2026-03-31$3.40M7.91%
2025-12-31$3.15M24.81%
2025-09-30$2.52M41.90%
2025-06-30$1.78M16.29%
2025-03-31$1.53M-21.55%
2024-12-31$1.95M7.68%
2024-09-30$1.81M4.08%
2024-06-30$1.74M15.09%
2024-03-31$1.51M-14.20%
2023-12-31$1.76M13.17%
2023-09-30$1.56M-5.64%
2023-06-30$1.65M33.09%
2023-03-31$1.24M20.76%
2022-12-31$1.03M-28.30%
2022-09-30$1.43M-6.53%
2022-06-30$1.53M29.42%
2022-03-31$1.18M-14.28%
2021-12-31$1.38M28.85%
2021-09-30$1.07M3.18%
2021-06-30$1.04M3.18%
2021-03-31$1.01M536.71%
2020-12-31$158.00K-83.88%
2020-09-30$980.00K213.10%
2020-06-30$313.00K-69.73%
2020-03-31$1.03M2.07%
2019-12-31$1.01M7.88%
2019-09-30$939.00K-30.65%
2019-06-30$1.35M226.27%
2019-03-31$415.00K-49.51%
2018-12-31$822.00K6.89%
2018-09-30$769.00K-23.33%
2018-06-30$1.00M-0.40%
2018-03-31$1.01M20.89%
2017-12-31$833.00K16.02%
2017-09-30$718.00K12.19%
2017-06-30$640.00K12.48%
2017-03-31$569.00K76.71%
2016-12-31$322.00K-31.34%
2016-09-30$469.00K-13.15%
2016-06-30$540.00K-4.09%
2016-03-31$563.00K9.11%
2015-12-31$516.00K-18.35%
2015-09-30$632.00K-7.74%
2015-06-30$685.00K43.61%
2015-03-31$477.00K-45.17%
2014-12-31$870.00K218.68%
2014-09-30$273.00K41.45%
2014-06-30$193.00K-86.98%
2014-03-31$1.48M-4.51%
2013-09-30$1.55M3.47%
2013-06-30$1.50M-0.92%
2013-03-31$1.51M12.15%
2012-12-31$1.35M165.23%
2012-09-30$509.00K-45.27%
2012-06-30$930.00K-18.28%
2012-03-31$1.14M-11.92%
2011-12-31$1.29M-34.94%
2011-09-30$1.99M90.96%
2011-06-30$1.04M-38.32%
2011-03-31$1.69M100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31--

InspireMD generated $3.40M in revenue during Q1 2026, up 7.91% compared to the previous quarter, and up 174.35% compared to the same period a year ago.

InspireMD Revenue Breakdown


InspireMD Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22
MGuard Prime EPS$48.00K
CGuard EPS$5.12M

InspireMD's latest annual revenue breakdown by segment (product or service), as of Dec 22: CGuard EPS (99.07%), and MGuard Prime EPS (0.93%).

Quarterly Revenue by Product

Product/ServiceSep 23Sep 22
CGuard EPS$1.56M-
CGuard-$1.43M

InspireMD's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: CGuard EPS (100.00%).

InspireMD Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24
ITALY$1.23M$1.22M
UNITED STATES$1.42M-
POLAND$1.04M-
Other Countries$4.06M$4.15M
GERMANY$1.23M$926.00K

InspireMD's latest annual revenue breakdown by geography, as of Dec 25: Other Countries (45.23%), UNITED STATES (15.78%), GERMANY (13.73%), ITALY (13.72%), and POLAND (11.54%).

Quarterly Revenue by Country

CountryMar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24
POLAND$301.00K$350.00K$211.00K$249.00K$226.00K$176.00K$207.00K$152.00K-
GERMANY$255.00K$251.00K$380.00K$360.00K$242.00K$71.00K$306.00K$307.00K$242.00K
Other Countries$1.31M$1.27M$1.14M$845.00K$799.00K$1.53M$832.00K$961.00K$822.00K
ITALY$354.00K$353.00K$293.00K$324.00K$262.00K$358.00K$306.00K$264.00K$295.00K
UNITED STATES$1.18M$920.00K$497.00K------

InspireMD's latest quarterly revenue breakdown by geography, as of Mar 26: Other Countries (38.55%), UNITED STATES (34.67%), ITALY (10.42%), POLAND (8.86%), and GERMANY (7.50%).

InspireMD Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
QIPTQuipt Home Medical$245.36M$82.24M
FONRFONAR$104.35M$2.03M
RCELAVITA Medical$71.61M$19.25M
EDAPEdap Tms$62.42M$17.81M
HYPRHyperfine$13.56M$3.90M
NSPRInspireMD$8.98M$3.40M
ORMPOramed Pharmaceuticals$2.00M-
CNTXContext Therapeutics--
MBOTMicrobot Medical-$105.00K
VANIVivani Medical--
IMAImageneBio--

NSPR Revenue FAQ


What is InspireMD’s yearly revenue?

InspireMD's yearly revenue for 2025 was $8.98M, representing an increase of 28.11% compared to 2024. The company's yearly revenue for 2024 was $7.01M, representing an increase of 12.96% compared to 2023. NSPR's yearly revenue for 2023 was $6.2M, representing an increase of 20.00% compared to 2022.

What is InspireMD’s quarterly revenue?

InspireMD's quarterly revenue for Q1 2026 was $3.4M, a 7.91% increase from the previous quarter (Q4 2025), and a 122.24% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $3.15M, a 24.81% increase from the previous quarter (Q3 2025), and a 61.57% increase year-over-year (Q4 2024). NSPR's quarterly revenue for Q3 2025 was $2.52M, a 41.90% increase from the previous quarter (Q2 2025), and a 39.39% increase year-over-year (Q3 2024).

What is InspireMD’s revenue growth rate?

InspireMD's revenue growth rate for the last 3 years (2023-2025) was 44.71%, and for the last 5 years (2021-2025) was 99.76%.

What are InspireMD’s revenue streams?

InspireMD's revenue streams in c 22 are MGuard Prime EPS, and CGuard EPS. MGuard Prime EPS generated $48K in revenue, accounting 0.93% of the company's total revenue CGuard EPS generated $5.12M in revenue, accounting 99.07% of the company's total revenue

What is InspireMD’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of InspireMD was CGuard EPS. This segment made a revenue of $5.12M, representing 99.07% of the company's total revenue.